Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Jones

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Persistent hepatitis C virus infection in microscale primary human hepatocyte culturesAlexander Ploss, Salman R Khetani, Christopher T Jones, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A InhibitorChristopher M Owens, Bradley B Brasher, Alex Polemeropoulos, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivoPhilip Meuleman, Maria Teresa Catanese, Lieven Verhoye, et al.
Hepatology (Baltimore, Md.)|December 7, 2011
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cellsLinda Andrus, Svetlana Marukian, Christopher T Jones, et al.
Cell|March 15, 2002
Structure of dengue virus: implications for flavivirus organization, maturation, and fusionRichard J Kuhn, Wei Zhang, Michael G Rossmann, et al.
Nature Biotechnology|February 2, 2010
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter systemChristopher T Jones, Maria Teresa Catanese, Lok Man J Law, et al.
Nature|June 10, 2011
A genetically humanized mouse model for hepatitis C virus infectionMarcus Dorner, Joshua A Horwitz, Justin B Robbins, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2014
Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitorsDavid Barnes-Seeman, Carri Boiselle, Christina Capacci-Daniel, et al.
Plos One|March 26, 2013
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansJohn Lok Man Law, Chao Chen, Jason Wong, et al.
Clinical Therapeutics|September 7, 2018
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter TrialEric Lawitz, Mohamed Bidair, Thomas Marbury, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Persistent hepatitis C virus infection in microscale primary human hepatocyte culturesAlexander Ploss, Salman R Khetani, Christopher T Jones, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A InhibitorChristopher M Owens, Bradley B Brasher, Alex Polemeropoulos, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivoPhilip Meuleman, Maria Teresa Catanese, Lieven Verhoye, et al.
Hepatology (Baltimore, Md.)|December 7, 2011
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cellsLinda Andrus, Svetlana Marukian, Christopher T Jones, et al.
Cell|March 15, 2002
Structure of dengue virus: implications for flavivirus organization, maturation, and fusionRichard J Kuhn, Wei Zhang, Michael G Rossmann, et al.
Nature Biotechnology|February 2, 2010
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter systemChristopher T Jones, Maria Teresa Catanese, Lok Man J Law, et al.
Nature|June 10, 2011
A genetically humanized mouse model for hepatitis C virus infectionMarcus Dorner, Joshua A Horwitz, Justin B Robbins, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2014
Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitorsDavid Barnes-Seeman, Carri Boiselle, Christina Capacci-Daniel, et al.
Plos One|March 26, 2013
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansJohn Lok Man Law, Chao Chen, Jason Wong, et al.
Clinical Therapeutics|September 7, 2018
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter TrialEric Lawitz, Mohamed Bidair, Thomas Marbury, et al.
Pageof 4